Arash Mostaghimi

Dermatology — Brigham and Women's Hospital, United States

LeadR Profile

Arash Mostaghimi Brigham and Women's Hospital United States
2 009 ScienceLeadR Reputation 2009
Network Map

Dermatology

Subspecialties: Public Health - Pharmacy - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2010 - 2026

Source: PubMed

Brigham and Women's Hospital

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 479

Citations

Citations: 6 494 1st author: 34 Last author: 231 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Clinical Outcomes in a Longitudinal Virtual Dermatology Care Model for Eczema and Psoriasis.
eczema, psoriasis, dermatology
Dermatol Pract Concept20260
Baricitinib Efficacy Through 4 Years in Responders and Safety up to 5 Years in Adults with Severe Alopecia Areata: Final Results from BRAVE-AA1 and BRAVE-AA2.
safety, alopecia areata, therapeutics, alopecia
Dermatol Ther (Heidelb)20260
Delphi Consensus Statement on Treatment of Severe Alopecia Areata in US Adults.
alopecia areata, skin diseases, surveys and questionnaires, research, therapeutics, alopecia
JAMA Dermatol20261
Oropharyngeal ulcers in Yao syndrome with multisystem involvement.
ulcer
Lancet Top journal20260
Upadacitinib for Severe Alopecia Areata in Adults and Adolescents: Two Phase 3 UP-AA Randomized Clinical Trials.
quality of life, achievement, safety, alopecia areata, skin diseases, drug-related side effects and adverse reactions, adolescent, therapeutics, alopecia
JAMA Dermatol20260

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

Phase 2 2
Phase 1/Phase 2 1
Phase 2/Phase 3 1
Phase 3 1

By status:

Recruiting 4
Completed 1

By type:

Interventional 5

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 5

Main Topics

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
NCT07533006 — safety, alopecia areata, pharmaceutical preparations, proof of concept study, alopecia
Phase 2Recruiting2026
A Study of LY4005130 in Adult Participants With Non Segmental Vitiligo
NCT07533019 — safety, pharmaceutical preparations, vitiligo, proof of concept study
Phase 2Recruiting2026
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
NCT06012240 — safety, alopecia areata, pharmaceutical preparations, tablets, adolescent, therapeutics, alopecia
Phase 3Recruiting2023

LeadR Networks

Main global connection map